CME
Changing Treatment Paradigms in Type 1 Diabetes: Role of Anti-CD3 Targeted Therapy -- Anti-CD3 Monoclonal Antibodies to Prevent/Delay Onset of Type 1 Diabetes
May 28, 2021
Guest: Kevan C. Herold, MD
Guest: Stephen Gitelman, MD
Experts in the immunopathology of type 1 diabetes consider the potential role of monoclonal antibodies, disease modifying agents, and other agents to prevent or delay the onset of clinical dise
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!